Screener
Eligibility screening
Extension Study of Long-term Safety and Efficacy of Tulisokibart
12 US sites in CT, MI, MO, NY +3
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Extension Study of Long-term Safety and Efficacy of Tulisokibart
12 US sites in CT, MI, MO, NY +3
Before we begin
Your answer affects how the questions are phrased.